Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Other
This study is looking at possible side effects of zoledronic acid, in women who took part in the AZURE trial. The AZURE trial is trying to find out if zoledronic acid helps to stop breast cancer coming back.
Recruitment start: 14 January 2010
Recruitment end: 29 June 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Robert Coleman
Experimental Cancer Medicine Centre (ECMC)
Novartis
University of Sheffield
Last reviewed: 22 August 2022
CRUK internal database number: 6410
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
